[video+transcript] Abiomed's Shares Doubled. What Happens Next?

Open-heart surgery in patients that have suffered major cardiovascular events is risky, but it could be getting less so thanks to temporary heart pumps sold by Abiomed (NASDAQ:ABMD), a $17 billion market-cap medical devices company.